Search clinical trials for: BNZ132-1-40

Total 15037 results

Bioniz Therapeutics

Completed

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

LGL Leukemia | CTCL

United States
Bioniz Therapeutics
Celerion

Completed

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Safety and Tolerability in Healthy Subjects

United States
Bioniz Therapeutics
Celerion

Completed

A First-in-Human Study of BNZ132-1-40

Healthy

United States
Université de Sherbrooke
Fondation Vitae

Completed

Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease (MCT-MA)

Alzheimer's Disease

Canada
Manchester University NHS Foundation Trust
Topcon Corporation; Optos, PLC

Withdrawn

Sub-threshold Photocoagulation of Diabetic Macular Oedema (MEM)

Diabetic Macular Oedema

United Kingdom
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment | Prodromal Alzheimer's Disease
Kadmon Corporation, LLC
Quotient Sciences

Completed

A Phase I Study to Evaluate the Taste of Belumosudil Oral Suspensions & Assess Relative Bioavailability

Healthy Volunteers

United Kingdom
BioNTech SE

Recruiting

Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors

Solid Tumor

United States, Spain, Singapore, United Kingdom
Duke University
American Heart Association

Terminated

Pacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial) (PACE-RBBB)

Heart Failure | Right Bundle-Branch Block

United States
BioNTech SE

Recruiting

Dose Escalation Trial of BNT152+153 in Patients With Cancer

Solid Tumor

United States, Czechia
Region Örebro County

Not yet recruiting

Regional Distribution of Ventilation at Different Respiratory Rates

Mechanical Ventilation | Atelectasis | Distribution of Ventilation
Yonsei University

Unknown

Influence of Central Sensitization on Efficacy of Patient-controlled Epidural Analgesia in Osteoarthritis Patients Undergoing Total Knee Replacement

Knee Osteoarthritis

Korea, Republic of
Boehringer Ingelheim

Completed

Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Hypertension | Coronary Arteriosclerosis

Germany
Breas Medical S.A.R.L.

Withdrawn

Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome (OVO)

Obesity Hypoventilation Syndrome

France
Fondazione Poliambulanza Istituto Ospedaliero

Completed

Prevention of Hypoglycaemia by Oral 40% Destrogel

Hypoglycaemia Neonatal

Italy
Jazz Pharmaceuticals

Terminated

Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine (GWMD09126)

Schizophrenia

United Kingdom
BioNova Pharmaceuticals (Shanghai) LTD.

Withdrawn

A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL

NHL | CLL/SLL

China
University of Zurich

Completed

Effects of Chocolate in Patients With Chronic Heart Failure

Heart Failure

Switzerland
Merck Sharp & Dohme LLC

Completed

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Papillomavirus Infections | Genital Diseases, Female
Zhongshan Ophthalmic Center, Sun Yat-sen University

Unknown

Development of the Glaucoma Visual Functioning Questionnaire-40 and Its Psychometric Properties

Primary Glaucoma | Glaucoma Suspect

China
Johns Hopkins University
National Institute on Aging (NIA)

Active, not recruiting

Sound and Music for Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Boehringer Ingelheim

Completed

Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy

Hypertension

Japan
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
US Department of Veterans Affairs
Abbott Diagnostics Division; Pan American Laboratories

Completed

Homocysteine Study (HOST)

Renal Failure | End Stage Renal Disease

United States, Puerto Rico
Betsi Cadwaladr University Health Board
Oxford Brookes University

Recruiting

Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19

Covid19 | Medical Emergencies

United Kingdom
Duke University

Completed

Breakfast Nutrition and Inpatient Glycemia

Hyperglycemia | Cardiovascular Disease | Diabetes, Type 2 | Diabetes, Type 1

United States
Chong Kun Dang Pharmaceutical

Completed

CKD-828 Telmisartan Non-Responder Trial

Hypertension

Korea, Republic of
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

Healthy

United States
Hospital General de México Dr. Eduardo Liceaga

Unknown

Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients

Hypertension | Obesity | Type 2 Diabetes Mellitus

Mexico
UroGen Pharma Ltd.

Completed

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Neoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms

India
Novartis

Terminated

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH)

Hypertension

United States, Denmark, Finland, Norway, Sweden
Boston Children's Hospital

Completed

Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury (Recruitment)

Acute Respiratory Distress Syndrome | Acute Lung Injury

United States
Zhongda Hospital
Sun Yat-sen University; Jiangsu Cancer Institute & Hospital; Zhejiang University and other collaborators

Not yet recruiting

A Real World Study of Regogfinib in HCC

Hepatocellular Carcinoma
Aarhus University Hospital
Odense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaborators

Completed

Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome. (DANPACEII)

Atrial Fibrillation | Sinus Node Disease

Denmark
Société des Produits Nestlé (SPN)

Completed

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO (LORIS-02)

Dietary Supplement

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

Healthy Subjects
Menarini Group
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Hypertension

Poland, Germany, Israel, Romania, Italy, Denmark, Czechia, Croatia
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions

Healthy Subjects
Sandoz

Completed

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration (Mylight)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
Genencell Co. Ltd.

Recruiting

Efficacy and Safety of ES16001 in Patients With COVID-19

COVID-19

Korea, Republic of
Humanitas Clinical and Research Center

Unknown

Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

Italy
University Hospital, Basel, Switzerland

Completed

Perianal Nerval Block in Proctological Interventions

Hemorrhoids | Perianal Fistula | Fissure in Ano

Switzerland
Institute of Cancer Research, United Kingdom
AstraZeneca; Astellas Pharma Inc; Prostate Cancer UK

Terminated

Combination Study of AZD5069 and Enzalutamide. (ACE)

Metastatic Castration Resistant Prostate Cancer

United Kingdom, Switzerland
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Healthy

Germany
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Completed

New Cross Linked Hyaluronan Gel After Deep Infiltrating Endometriosis Surgery (HYALOENDOQoL)

Quality of Life | Endometriosis | Surgery | Adhesion
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy

Advanced Solid Tumor

United States
Novo Nordisk A/S

Completed

A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations

Non-alcoholic Steatohepatitis

Canada
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions

Healthy

United States
George Papanicolaou Hospital

Unknown

Acute Effects of Oxygen Supplementation Among IPF Patients

Idiopathic Pulmonary Fibrosis

Greece

Search clinical trials for: BNZ132-1-40

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations